RegulatoryID Newsletter

One Upcoming International Disclosure Deadline

RegulatoryID August 2026 monthly newsletter coverMonthly issue
MedPro Systems
Published
Issue
Subscribe

This month highlights an upcoming international disclosure deadline for France’s semiannual reporting requirement. The summary below covers who is affected, what is due and where it is filed. Subscribers get the full requirements, source links and submission details.


International

France Semiannual Disclosure Due 9/1

Semiannual disclosure under the French Sunshine Act is due September 1 to the French Ministry of Health and Access to Healthcare. The French Sunshine Act requires pharmaceutical and medical device companies, both French and foreign, to semiannually report the benefits granted to reportable beneficiaries who practice or are located in France. 

Eiffel Tower above the Seine in Paris at dusk

Key Date

September 1, 2026

Filing Platform

Transparence-Santé


About the Newsletter

Why Subscribe

Each edition draws from RegulatoryID, MedPro’s expert-maintained reference covering transparency and compliance requirements across 50+ countries. The team that maintains the compendium also curates each newsletter, surfacing the deadlines, filings and rule changes most relevant to Life Sciences manufacturers, distributors and medical device companies in the month ahead. Sign up and receive:

Monthly Newsletter

A single monthly newsletter delivered the first Tuesday of each month, covering U.S. and international jurisdictions

Quick Summaries

Concise high-level summaries in the email so you can quickly scan deadlines and what's required

Detailed Summaries

Linked detailed summaries with full regulatory context, deadlines and reference links

Urgent Alerts

Immediate alerts for urgent developments that cannot wait for the next monthly send

Keep reading

Related resources

Back to Resource Center